Your browser doesn't support javascript.
loading
Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma.
Newhook, Timothy E; Vreeland, Timothy J; Griffin, James F; Tidwell, Rebecca S S; Prakash, Laura R; Koay, Eugene J; Ludmir, Ethan B; Smaglo, Brandon G; Pant, Shubham; Overman, Michael; Wolff, Robert A; Ikoma, Naruhiko; Maxwell, Jessica; Kim, Michael P; Lee, Jeffrey E; Katz, Matthew H G; Tzeng, Ching-Wei D.
Affiliation
  • Newhook TE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Vreeland TJ; Department of Surgery, Brooke Army Medical Center, San Antonio, TX.
  • Griffin JF; Piedmont Physicians Athens Surgical Oncology, Athens, GA.
  • Tidwell RSS; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Prakash LR; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Koay EJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ludmir EB; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Smaglo BG; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pant S; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Overman M; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wolff RA; Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ikoma N; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Maxwell J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kim MP; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Tzeng CD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Ann Surg ; 277(3): 484-490, 2023 03 01.
Article in En | MEDLINE | ID: mdl-36649067

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Carcinoma, Pancreatic Ductal Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Surg Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Carcinoma, Pancreatic Ductal Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Surg Year: 2023 Type: Article